Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
Undergraduate Program in Biochemistry, West Virginia University, Morgantown, WV, USA.
Sci Rep. 2022 Sep 15;12(1):15535. doi: 10.1038/s41598-022-19910-1.
The interphotoreceptor matrix (IPM) is a specialized extracellular mesh of molecules surrounding the inner and outer segments of photoreceptor neurons. Interphotoreceptor matrix proteoglycan 1 and 2 (IMPG1 and IMPG2) are major components of the IPM. Both proteoglycans possess SEA (sperm protein, enterokinase and agrin) domains, which may support proteolysis. Interestingly, mutations in the SEA domains of IMPG1 and IMPG2 are associated with vision disease in humans. However, if SEA domains in IMPG molecules undergo proteolysis, and how this contributes to vision pathology is unknown. Therefore, we investigated SEA-mediated proteolysis of IMPG1 and IMPG2 and its significance to IPM physiology. Immunoblot analysis confirmed proteolysis of IMPG1 and IMPG2 in the retinas of wildtype mice. Point mutations mimicking human mutations in the SEA domain of IMPG1 that are associated with vision disease inhibited proteolysis. These findings demonstrate that proteolysis is part of the maturation of IMPG1 and IMPG2, in which deficits are associated with vision diseases. Further, immunohistochemical assays showed that proteolysis of IMPG2 generated two subunits, a membrane-attached peptide and an extracellular peptide. Notably, the extracellular portion of IMPG2 trafficked from the IPM around the inner segment toward the outer segment IPM by an IMPG1-dependent mechanism. This result provides the first evidence of a trafficking system that shuttles IMPG1 and IMPG2 from the inner to outer IPM in a co-dependent manner. In addition, these results suggest an interaction between IMPG1-IMPG2 and propose that mutations affecting one IMPG could affect the localization of the normal IMPG partner, contributing to the disease mechanism of vision diseases associated with defective IMPG molecules.
光感受器细胞间基质(IPM)是围绕光感受器神经元内节和外节的一种特殊的细胞外分子网格。 光感受器细胞间基质糖蛋白 1 和 2(IMPG1 和 IMPG2)是 IPM 的主要成分。 两种糖蛋白都具有 SEA(精子蛋白、肠激酶和聚集素)结构域,这可能支持蛋白水解。 有趣的是,IMPG1 和 IMPG2 的 SEA 结构域突变与人类的视觉疾病有关。 然而,如果 IMPG 分子的 SEA 结构域发生蛋白水解,以及这如何导致视觉病理尚不清楚。 因此,我们研究了 IMPG1 和 IMPG2 的 SEA 介导的蛋白水解及其对 IPM 生理学的意义。 免疫印迹分析证实了野生型小鼠视网膜中 IMPG1 和 IMPG2 的蛋白水解。 模拟与视觉疾病相关的 IMPG1 的 SEA 结构域中的人类突变的点突变抑制了蛋白水解。 这些发现表明蛋白水解是 IMPG1 和 IMPG2 成熟的一部分,其中缺陷与视觉疾病有关。 此外,免疫组织化学检测表明,IMPG2 的蛋白水解产生了两个亚基,一个膜附着肽和一个细胞外肽。 值得注意的是,通过 IMPG1 依赖的机制,IMPG2 的细胞外部分从 IPM 围绕内节向 IPM 的外节迁移。 这一结果首次提供了一种从内 IPM 到外 IPM 以共依赖方式转运 IMPG1 和 IMPG2 的转运系统的证据。 此外,这些结果表明 IMPG1-IMPG2 之间存在相互作用,并提出影响一种 IMPG 的突变可能会影响正常 IMPG 伴侣的定位,从而导致与缺陷 IMPG 分子相关的视觉疾病的发病机制。